Analyst firms · Leerink Partners · ALVR

Leerink Partners ALVR price target and rating history

AlloVir Inc. (ALVR) · Health Care

Leerink Partners rates AlloVir Inc. (ALVR) Market Perform with a $30 price target, as of its latest action on Dec 22, 2023. It has published 4 rating actions on ALVR since November 2021, including 0 upgrades and 1 downgrade.

Current rating
Market Perform
Price target
$30
Median target, all firms
Too few
Actions on ALVR
4

Leerink Partners price target on ALVR

$37$34$3020222023202420252026
Leerink Partners price target on ALVR, each point a stated target, November 2021 to February 2022.

Every Leerink Partners rating on ALVR

Questions about Leerink Partners and ALVR

What is Leerink Partners's price target for ALVR?
Leerink Partners's latest stated price target for AlloVir Inc. (ALVR) is $30, from its action on Feb 10, 2022.
What is Leerink Partners's rating on ALVR?
Leerink Partners rates ALVR Market Perform, a neutral rating, as of Dec 22, 2023.
When did Leerink Partners last change its view on ALVR?
On Dec 22, 2023, Leerink Partners downgrades to Market Perform from Outperform.

More ALVR rating histories

All Leerink Partners ratingsALVR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.